Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury

S G Soriano1, A Coxon, Y F Wang

  • 1Department of Anesthesia, Children's Hospital, Boston, MA 02115, USA. soriano@A1.tch.harvard.edu

Stroke
|January 8, 1999
PubMed
Abstract

Insights

Macrophage-1 antigen (Mac-1) deficiency significantly reduced brain infarction volume and neutrophil infiltration in mice after stroke. This suggests Mac-1 plays a key role in stroke-related brain injury.

Area of Science:

  • Neuroscience
  • Immunology
  • Cardiovascular Biology

Background:

  • Macrophage-1 antigen (Mac-1) is a leukocyte integrin involved in neutrophil adhesion and migration.
  • Mac-1 may contribute to reperfusion injury in ischemic brain tissue, such as in stroke.

Purpose of the Study:

  • To investigate the role of Mac-1 in the brain during focal cerebral ischemia and reperfusion.
  • To analyze the effects of Mac-1 deficiency on stroke outcomes in a mouse model.

Main Methods:

  • Transient focal cerebral ischemia was induced in Mac-1-deficient and wild-type mice.
  • Infarct volume was measured using 2,3,5-triphenyltetrazolium chloride staining.
  • Neutrophil accumulation was quantified via dichloroacetate esterase staining.

Main Results:

  • Mac-1-deficient mice exhibited a 26% reduction in infarct volume compared to wild-type mice.
  • A trend towards reduced neutrophil extravasation was observed in Mac-1-deficient mice.
  • No significant differences in regional cerebral blood flow were detected between groups.

Conclusions:

  • Mac-1 deficiency reduces cerebral cell death and neutrophil infiltration following transient focal cerebral ischemia.
  • Reduced neutrophil extravasation in Mac-1-deficient mice may underlie the observed neuroprotective effect.

Related Concept Videos